GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » Total Operating Expense

AdAlta (ASX:1AD) Total Operating Expense : A$5.89 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is AdAlta Total Operating Expense?

AdAlta's Total Operating Expense for the six months ended in Dec. 2024 was A$2.91 Mil. AdAlta's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$5.89 Mil.


AdAlta Total Operating Expense Historical Data

The historical data trend for AdAlta's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AdAlta Total Operating Expense Chart

AdAlta Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Total Operating Expense
Get a 7-Day Free Trial 2.66 9.40 8.75 8.34 7.06

AdAlta Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.91 4.44 4.09 2.98 2.91

AdAlta Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$5.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AdAlta Total Operating Expense Related Terms

Thank you for viewing the detailed overview of AdAlta's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


AdAlta Business Description

Industry
Traded in Other Exchanges
N/A
Address
Science Drive, La Trobe Institute for Molecular Science, Room 204, LIMS2, La Trobe University, Bundoora, VIC, AUS, 3086
AdAlta Ltd is engaged in drug discovery and developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The principal business of AdAlta is the discovery and development of next-generation protein and cell-based therapeutics. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis and CAR-T cancer therapeutics.

AdAlta Headlines

No Headlines